Medicare covers Eli Lilly's GLP-1 medications starting July! Morgan Stanley raises market volume to $190 billion!
Reading Time: 3 minutes
Milestone in the USA: Starting July 2026, millions of seniors will gain access to GLP-1 medications through the Medicare Bridge Program for only $50 per month Expansion in Europe: The European EMA recommends the approval of Lilly's cancer drug Jaypirca and weekly insulin Onswik Market Dynamics: The total GLP-1 market is projected to reach $190 billion by 2035, driving healthcare stocks to all-time highs The US pharmaceutical giant Eli Lilly (LLY) is poised for a significant sales boost in its domestic market. Starting July 1, 2026, the...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
